Wednesday - May 08, 2024

Surging Semiconductor Sales and Notable Innovations: Spotlight Nasdaq Small-Caps: PRSO, NVTS, INDI, AIP, INBS and NVIDIA

Semiconductor sales have surged significantly, reaching $50.6 billion in March 2024. This marks a 16.4% increase from the previous month and a 15.7% year-over-year growth, according to the Semiconductor Industry Association. These figures exceeded Citibank’s projections. This feature will delve … Continue reading

New Book Series by Travis Eugene Williams Inspires Incarcerated Individuals Towards Self-Improvement and Entrepreneurship

Forward-thinking and inspirational inmate author empowers prisoners through an educational series of books focused on self-improvement, entrepreneurship, self-rehabilitation and anti-recidivism. Author, publisher, and entrepreneur Travis Eugene Williams has announced the launch of a groundbreaking book series aimed at educating and … Continue reading

COVID-19 Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated)

DelveInsight’s, “COVID-19 Pipeline Insight 2024” report provides comprehensive insights about 400+ companies and 400+ pipeline drugs in the COVID-19 pipeline landscape. It covers the COVID-19 pipeline drug profiles, including clinical and nonclinical stage products. It also covers the COVID-19 therapeutics assessment by product type, … Continue reading

Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials and Companies 2024 (Updated)

DelveInsight’s, “Chronic Kidney Disease Pipeline Insight 2024” report provides comprehensive insights about 76+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Bladder Cancer Pipeline Outlook, FDA Approvals, Clinical Trials, and Companies 2024 (Updated)

DelveInsight’s, “Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bladder Cancer pipeline … Continue reading